Introduction: A four-layer ROI model connects device use, consumables, failed studies and support to six operational metrics that determine completed-study cost.
ROI Begins with Completed Studies, Not Device Units
A device creates value when a usable recording reaches clinical review and supports the next decision. The denominator should therefore be the completed study, not the fleet, kit shipment, or app account. A lower hardware price can disappear into failed fitting, repeat nights, support labor, and delayed review.
From Purchase Price to Cost per Usable Study
Total operating cost should include acquisition, freight, taxes, installation, training, consumables, software, integration, support, replacement, and staff time. Divide that cost by studies that pass the program's quality rule over the same period. A completed study should mean usable recording, quality review, report production, and clinical handoff, not merely a returned kit.
Define the Numerator and Denominator in Writing
Include Clinical Review in the Completion Rule
A usable recording has no financial value if the report cannot be reviewed or handed to the next care step. The completion rule should identify the quality threshold, reviewer role, report status, and handoff record. Count studies that finish the full pathway within the study period. This prevents a program from reporting high device output while reports wait in a queue or return to the clinic for correction.
Finance, clinical, and operations owners should agree on the period, device allocation method, labor rates, repeat-study treatment, and quality threshold before the pilot. Otherwise one team can count returned kits while another counts reviewed reports, producing different ROI from the same data.
Why Device Count Can Mislead
Ten devices do not create ten studies per night if patients are not scheduled, kits are not cleaned, or clinicians cannot review reports. Distinguish purchased capacity, in-service capacity, scheduled capacity, and completed output. Test conservative, expected, and constrained scenarios so that the program does not depend on every device working every eligible night.
Device Cost and Utilization
Device economics start with the total cost of placing a functioning unit into service. Hardware quotes may exclude sensors, chargers, cases, freight, import charges, setup, software, training, spare parts, or local registration.
Build a Total Acquisition and Utilization Model
Create a cost schedule by component and year, then amortize it over a realistic service life. Test a shorter replacement case if software, regulation, or repair risk may reduce useful life. Utilization is a workflow property: cleaning, fitting, consumables, and review can constrain capacity even when devices are idle. Model the smallest capacity among those steps.
Separate Fleet Capacity from Usable Output
Report available device-nights, study nights used, recordings that passed quality review, and reports handed to clinicians. A rising kit count with falling completed output points to a bottleneck after dispatch, not to a need for more hardware.
Consumables and Sensor Economics
Consumables should be evaluated by cost per completed study rather than cost per box. A cheaper sensor can create more unusable traces and support work, while a higher-priced sensor may reduce repeat exposure if it is easier to fit.
Map Approved Sensors and Calculate Their Cost
The technical file should identify approved sensor types, part numbers, lots, compatible firmware, shelf life, storage, cleaning limits, and replacement criteria. Include initial and repeat studies, plus waste from training and kit reset, in the consumable numerator. Compare cost per first-pass completion with cost per completed study to expose fitting and trace-quality losses.
Check Supply Continuity and Shelf-Life Loss
Single-source accessories can halt a program during a shortage. Record lead times, minimum orders, expiry loss, damaged stock, patient-fit rejects, and early replacements. Validate alternatives before a supply interruption forces an unapproved substitution.
Failure Records and Repeat-Test Exposure
Failure includes power, pairing, fitting, signal gaps, upload, reporting, return, and scheduling problems. Grouping them into one technical rate hides whether the correction belongs to product design, patient instruction, logistics, or clinical process.
Use Cause Codes and Measure First-Pass Completion
Separate device, consumable, patient, process, software, and reporting failures. Record whether a repeat was clinically necessary and whether the event was preventable. Calculate first-pass completion as initial studies meeting the quality rule divided by initial starts. Track repeat rate and time to resolution so that lost queue capacity is visible, not only the extra sensor cost.
Make Cause Codes Actionable
Connect Failure Events to Capacity and Cost
Each failure consumes more than the cost of a replacement sensor. It can hold a device, delay a dispatch slot, occupy support staff, displace another patient, and consume review time. Add the repeat night, administrative work, shipping, cleaning, and lost device capacity to the event record. A useful failure report shows the frequency of each cause and the operational cost per event, then tests whether a corrective action reduced both the next month.
Use enough categories to identify a fix but not so many that staff code inconsistently. Review ambiguous cases during the pilot and assign each major cause to an owner. The output should change instructions, training, sensor selection, support scripts, or device configuration.
Technical Support and Service Cost
Support includes patient help, device reset, connectivity, upload, report access, repair, and replacement administration. Its cost is internal labor as well as any supplier fee, and it rises when roles or escalation paths are unclear.
Measure Support Minutes and Repair Turnaround
Track internal and supplier support minutes per 100 completed studies by issue type. Define first-line and second-line ownership, required evidence, and escalation time. Model repair and replacement turnaround as lost device capacity; advance replacement or spare units may be necessary even when the purchase price is lower.
Define Recovery Before Service Credits
Escalation should distinguish a patient unable to start a study from a device that has stopped recording or a report that cannot be accessed. Each case needs a different response clock. Record who can authorize a reset, replacement, or repeat night, and when the supplier must join the case. A service credit may compensate part of the fee, but it does not recover the empty device night, the patient disruption, or the clinical queue time.
The contract should name the first contact, next-level owner, diagnostics, response time, and point at which a workaround or replacement begins. Service credits do not restore a patient pathway by themselves. Data continuity and service recovery should take priority.
Software, Integration, and Data-Governance Cost
Software determines whether data can move from device to clinician. The budget should include configuration, interface validation, user administration, security review, report design, retention, and ongoing support.
Define Integration Ownership and Error Handling
Specify patient matching, fields, units, timing, authentication, encryption, retries, rejected records, and the party responsible for correction. Describe the deliverable in an interface control document. Test duplicate identifiers, late uploads, partial files, version mismatch, and an unavailable receiving system before accepting the integration.
Include Retention, Exit, and Portability
Test export and migration before volume reaches the contracted maximum. Confirm that raw source data, derived fields, report versions, and audit history remain usable outside the supplier platform. Price the staff time and technical work required for those tasks. Software updates also carry validation, retraining, and workflow-change cost, so the budget should include a recurring review allowance rather than treating the launch release as permanent.
Record where data reside, who has access, how access is removed, how long records remain, and how source data are exported or deleted at contract end. Exit migration is a real cost of ownership and a future price risk if portability is undefined.
Four-Layer ROI Model
The four layers separate costs by the operating event that management can control. Use one defined study period and completion rule so that every layer shares the same denominator.
| ROI layer | Main inputs | Operating question | Evidence source | Management lever |
|---|---|---|---|---|
| Device | Purchase, freight, setup, service life, spares | How much usable capacity is available? | Asset and utilization log | Fleet and scheduling |
| Consumable | Sensors, accessories, shelf life, waste | What does each completed study consume? | Inventory and lot records | Fit training and stock control |
| Failure | Repeat study, labor, shipping, delay, lost capacity | Why did the first attempt fail? | Cause-coded failure log | Corrective action |
| Support | Calls, escalation, repair, replacement, software help | How much labor keeps studies moving? | Case and time records | Scripts, training, service levels |
Software and governance can be allocated across these layers or shown as a shared program cost. Every material assumption should have an owner and an evidence source.
Six Operational Metrics for Project Evaluation
These metrics connect the layers to cost per completed study. Set program-specific baselines, targets, and review thresholds rather than borrowing universal benchmarks.
| Metric | Calculation | Why it matters | Data owner |
|---|---|---|---|
| Device utilization | Study nights used divided by available device nights | Shows idle or constrained capacity | Operations |
| First-pass completion | Initial studies meeting quality rule divided by starts | Exposes fitting and trace loss | Clinical operations |
| Repeat-study rate | Repeat studies divided by completed initial studies | Quantifies avoidable rework | Program manager |
| Consumable cost per completed study | Approved consumable spend divided by completed studies | Links sensor spend to output | Finance |
| Report turnaround | Recording end to clinical handoff | Shows review capacity and delay | Clinical lead |
| Support minutes per 100 studies | Support minutes divided by completed studies times 100 | Makes labor and escalation visible | Support manager |
A pilot calculation should follow a fixed sequence:
1. Define the study period and completed-study rule.
2. Count available device-nights and nights used.
3. Record initial starts, first-pass completions, repeats, and causes.
4. Allocate device, consumable, support, software, and integration cost to the period.
5. Collect internal and supplier support minutes by issue type.
6. Measure recording end to clinical handoff.
7. Calculate cost per completed study under conservative, expected, and constrained scenarios.
8. Review the result with clinical, finance, operations, IT, and supplier owners.
Application Context
The model changes with the care setting because the limiting resource changes. Hospitals carry review capacity, telehealth programs carry logistics and remote support, and distributors carry inventory and service obligations.
Hospitals and Sleep Clinics
A clinic needs repeatable intake, clear instructions, trace-quality review, and an accountable clinician. The pilot should show whether home testing expands access without creating an unreviewed backlog. Fitting, cleaning, troubleshooting, and report review belong in the capacity model.
Treat Clinical Review as a Constraint
The clinical lead should define eligibility, adequate-trace rules, and escalation for incomplete or ambiguous results. More devices cannot increase completed output beyond the team's ability to review them safely.
Telehealth and Remote Programs
A remote program must manage consent, kit delivery, setup support, connectivity, return, cleaning, upload, and follow-up. Measure time from dispatch to clinical handoff. Battery margin can absorb delay, but it cannot replace an owned support queue or return process.
Test the Full Patient Journey
Include a failed first night, support call, late return, upload error, and clinical review in the pilot script. Each handoff needs an owner, timestamp, and escalation route.
Distributors and Integrators
A distributor needs a complete dossier, local training, spare stock, and a manufacturer escalation path. An integrator needs interface documents, test data, version control, and responsibility for receiving-system errors. Both should price the installed-base support obligation, not only the initial order margin.
Case Example
BERRY's BM2000A wrist-worn home sleep test device is a useful worked example. BERRY's product material describes a wrist unit with a fingertip sensor, SpO2 and pulse-rate monitoring, Bluetooth, the Berry Smart Health app, more than 20 hours of stated battery operation, plethysmogram output, ODI, desaturation events, cloud review, and integration with multi-parameter diagnostic software.
Those features can affect several ROI layers. Battery margin may absorb delayed start or handling; the app and cloud path may reduce manual transfer while adding support and governance work; the wrist and fingertip split may improve optical contact while adding fitting, cleaning, and connection checks. Each effect should be observed in the pilot.
BERRY Features That Belong in the Pilot
Test setup and connection success, trace quality, realistic battery handling, app comprehension, upload completion, report access, support contacts, and the source of ODI and desaturation calculations. Confirm which fields BERRY produces and which are calculated or edited downstream.
Separate Product Features from Financial Outcomes
A battery rating, app, or cloud workflow is a product input, not proof of savings. The financial result depends on completed studies, staff time, and how the clinical pathway uses the output. BERRY's BM2000A wrist pulse oximeter should use the same measured denominators as every alternative, without a promised payback period.
What the Available Evidence Does Not Establish
Public material does not provide a program-level ROI, guaranteed repeat rate, or service cost per study. It also does not resolve classification and certification differences across BERRY's pages. Request a model-specific regulatory matrix, sensor list and replacement rules, interface documentation, support workflow, response times, and pilot protocol. Keep those gaps in the evidence review, not in an optimistic spreadsheet.
Frequently Asked Questions
Q1: What is the correct ROI denominator?
A: Use the completed study defined by the program, including a usable recording, quality review, report, and clinical handoff. Device units and kits shipped measure activity, not usable output.
Q2: Does a lower device price improve ROI?
A: Not necessarily. Consumables, repeats, support labor, software, and replacement delay can offset the saving. Compare total cost per completed study under identical assumptions.
Q3: How should failures be categorized?
A: Use device, consumable, patient, process, software, and reporting codes. Record the cause, corrective action, preventability, and whether a repeat was clinically necessary.
Q4: Which pilot metrics matter most?
A: Review device utilization, first-pass completion, repeat rate, consumable cost per completed study, report turnaround, and support minutes per 100 studies together.
Q5: How should support cost be estimated?
A: Measure internal and supplier support minutes by issue type and divide them by completed studies. Include calls, escalation, reset, connectivity, upload, and replacement administration.
Q6: What software costs are often missed?
A: Interface validation, user administration, security review, report design, backup, retention, change control, and exit migration are often omitted from the hardware quote.
Q7: How can a pilot avoid overstating savings?
A: Use three scenarios, label every assumption, keep the four cost layers separate, and do not treat theoretical capacity or best-case service life as realized output.
Q8: What should buyers ask BERRY before modeling BM2000A ROI?
A: Request the exact configuration and market authorization, approved sensors, support and replacement terms, data dictionary, interface responsibilities, and pilot evidence for fitting and completion.
Conclusion
Home sleep screening economics improve when the program manages the distance between a device in inventory and a completed study. Device utilization, consumable control, failure records, support labor, software governance, and clinical review all contribute to that distance. The four-layer model and six metrics make their contribution visible.
BERRY's BM2000A wrist pulse oximeter illustrates why product features should be measured rather than assumed. The strongest ROI case is not a promised payback. It is a reproducible record of what each completed study costs under the buyer's real workflow.
References
Sources
- Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea
https://pmc.ncbi.nlm.nih.gov/articles/PMC5337595/
Note: Defines the clinical role and limitations of home sleep apnea testing within adult diagnostic pathways.
- Performance of Type III Home Sleep Apnea Tests
https://pmc.ncbi.nlm.nih.gov/articles/PMC12755673/
Note: Supports the distinction between overall agreement and accuracy at clinically important disease thresholds.
- Wrist-Worn Pulse Oximeter for Obstructive Sleep Apnea Screening
https://pmc.ncbi.nlm.nih.gov/articles/PMC11421761/
Note: Illustrates how wrist-based oximetry has been evaluated for sleep apnea screening and why study context matters.
- Validation of a Wrist-Worn Type IV Sleep Monitor
https://pmc.ncbi.nlm.nih.gov/articles/PMC12912879/
Note: Provides device-specific sensitivity, specificity, and AUC figures that should not be transferred to another model.
- Influence of Skin Pigmentation on Pulse Oximetry Accuracy
https://pmc.ncbi.nlm.nih.gov/articles/PMC12723707/
Note: Reviews evidence of SpO2 overestimation in darker skin and the need for representative validation.
- Economic Evaluations of Obstructive Sleep Apnea Diagnosis and Treatment
https://pmc.ncbi.nlm.nih.gov/articles/PMC13721662/
Note: Frames the economic questions that surround diagnosis, treatment pathways, and resource use.
- Home Testing for Obstructive Sleep Apnea: Systematic Review and Economic Evaluation
https://pmc.ncbi.nlm.nih.gov/articles/PMC13548101/
Note: Shows why home testing should be assessed as a pathway rather than a standalone device purchase.
- Service Evaluation of a Digital Obstructive Sleep Apnea Pathway
https://pmc.ncbi.nlm.nih.gov/articles/PMC13382708/
Note: Demonstrates the operational role of triage, remote data handling, and review capacity in digital sleep services.
- Pulse Oximeters
https://www.fda.gov/medical-devices/products-and-medical-procedures/pulse-oximeters
Note: Explains regulatory and performance considerations for pulse oximeter devices in the United States.
- Reprocessing Reusable Medical Devices
Note: Supports verification of validated cleaning, disinfection, and reuse instructions for reusable components.
- Regulation (EU) 2017/745 on Medical Devices
https://eur-lex.europa.eu/eli/reg/2017/745/oj
Note: Provides the legal framework for European medical device classification, conformity, and post-market obligations.
- ISO 13485 Medical Device Quality Management Systems
https://www.iso.org/standard/59752.html
Note: Describes the quality management standard that buyers can verify without treating certification as product authorization.
Related Examples
- BERRY BM2000A Home Sleep Test Device
https://berrytelmed.com/pages/bm2000a-home-sleep-test-device
Note: Provides the published device type, specifications, app, outputs, and certification statements used in the case example.
- BERRY Home Sleep Screening Device Product Page
https://berrytelmed.com/products/home-sleep-screening-device
Note: Provides the original product description, intended applications, and workflow claims for procurement review.
- BERRY Home Sleep Apnea Testing Devices
https://berrytelmed.com/pages/sleep
Note: Shows the broader sleep portfolio context and the classification and regulatory statements that require reconciliation.
Further Reading
- Designing a Home Sleep Test Around the Night
https://www.industrysavant.com/2026/11/designing-home-sleep-test-around-night.html
Note: Adds product-development context on sensor fit, battery margin, signal quality, and the home workflow.
Comments
Post a Comment